HOME >> MEDICINE >> NEWS
Forget basal body temperature -- check out her clothes

Was Chris De Burgh's sexy "Lady in Red," perhaps, ovulating? A new UCLA and University of Wisconsin-Eau Claire study finds evidence that women put more effort into their clothing and grooming during their most fertile periods.

"Near ovulation, women dress to impress, and the closer women come to ovulation, the more attention they appear to pay to their appearance," said Martie Haselton, the study's lead author and a UCLA associate professor of communication studies and psychology. "They tend to put on skirts instead of pants, show more skin and generally dress more fashionably."

Conventional wisdom has long held that humans hide all signs of ovulation, even from themselves and their mates. Indeed, numerous scientific studies have been devoted to identifying what the evolutionary advantage might be to disguising fertility.

Yet the study, which publishes Oct. 10 in the online version of the scholarly journal Hormones and Behavior, found that even total strangers could detect a difference in women's grooming habits when they approached ovulation.

"The thing that's so remarkable about this effect is that it's so easily observed," said April Bleske-Rechek, the study's co-author and an assistant professor of psychology at University of Wisconsin-Eau Claire. "In our study, the approach of ovulation had a stronger impact on the way women dressed than the onset of menstruation, which is notorious for its supposedly deleterious impact."

Haselton, Bleske-Rechek and three UCLA students tracked 30 college coeds in committed relationships through an entire ovulatory cycle. Using urine tests that are nearly as accurate for determining ovulation as ultrasounds, they ascertained each woman's most fertile period -- about 10 to 15 days after menstruation -- and their least fertile period -- roughly the two weeks following ovulation. The researchers photographed the women twice: once in their fertile (follicular) phase and anot
'"/>

Contact: Meg Sullivan
msullivan@support.ucla.edu
310-825-1046
University of California - Los Angeles
9-Oct-2006


Page: 1 2 3 4

Related medicine news :

1. Forgetful? You may be losing more than just your memory
2. Forget the label. Portion size is all in your mind
3. Lowering body temperature could aid standard stroke treatment
4. FDA approves room temperature storage of ZLB Behrings Helixate FS
5. Metacognition: Faced with a test, rats can check their knowledge first
6. Tech-check-tech
7. Regular exercise, keeping weight in check reduces breast-cancer risk in postmenopausal women
8. AIDS, TB, malaria and bird flu spread unchecked in Burma
9. Simple checklists could improve child protection
10. After gastric bypass surgery, important to check vitamin B1 deficiency
11. Physicians: Simple instrument allows medical staff to check patients literacy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Forget basal body temperature check out her clothes

(Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since 2004, the ... 26th as Mesothelioma Awareness Day . On this day, and in the weeks ... of becoming involved and helping the cause. , “One of the ways a person ...
(Date:8/31/2015)... ... August 31, 2015 , ... Chicago-based company The Mood ... to raise money and awareness for breast and ovarian health. During September ... incandescent Mood-lite sold to Bright Pink® to encourage households, dorms, and offices around ...
(Date:8/31/2015)... ... 31, 2015 , ... The Brooks Group, a global sales ... department devoted to helping organizations identify and keep the best talent both inside ... Brooks Group believes in offering a solution that goes beyond simply providing assessments ...
(Date:8/31/2015)... ... August 31, 2015 , ... ERT, a leading global provider ... solutions will demonstrate multiple prototypes from its Innovation Lab during its 8th Annual ... the only European event dedicated to providing case studies and pragmatic information on ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... certifies products for the water, food, health sciences and consumer goods industries, has ... for their advanced iron filtration media, Pro-OX Manganese Dioxide. , Developed by a ...
Breaking Medicine News(10 mins):Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 3Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 2Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 3
(Date:8/31/2015)... PRINCETON, N.J. , Aug. 31, 2015  /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today it has ... by the Data Review Committee (DRC) earlier this ... SGX942.  SGX942 is a first-in-class innate defense regulator ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, ... on the emerging field of regenerative medicine, today ... at Chicago -based Rush University ... evaluating activity of escalating doses of AST-OPC1 (oligodendrocyte ... and motor complete cervical spinal cord injury (SCI). ...
(Date:8/31/2015)... and STAMFORD, Conn. , Aug. ... of Eisai Co., Ltd., and Purdue Pharma L.P. announced ... agreement for the development and commercialization of Eisai,s clinical ... antagonist entering Phase III clinical development for the treatment ... the agreement, Eisai and Purdue Pharma will share the ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
Cached News: